WEBVTT
Kind: captions
Language: en

00:00:07.490 --> 00:00:09.919 

MDA<00:00:08.490> funded<00:00:09.059> researchers<00:00:09.690> are<00:00:09.900> looking

00:00:09.919 --> 00:00:09.929 
MDA funded researchers are looking

00:00:09.929 --> 00:00:12.620 
MDA funded researchers are looking
closely<00:00:10.559> at<00:00:10.800> a<00:00:10.980> molecule<00:00:11.460> called<00:00:11.670> myostatin

00:00:12.620 --> 00:00:12.630 
closely at a molecule called myostatin

00:00:12.630 --> 00:00:15.140 
closely at a molecule called myostatin
which<00:00:13.410> could<00:00:13.650> potentially<00:00:13.799> play<00:00:14.490> a<00:00:14.549> role<00:00:14.880> in

00:00:15.140 --> 00:00:15.150 
which could potentially play a role in

00:00:15.150 --> 00:00:16.670 
which could potentially play a role in
the<00:00:15.179> development<00:00:15.420> of<00:00:15.990> treatments<00:00:16.199> for

00:00:16.670 --> 00:00:16.680 
the development of treatments for

00:00:16.680 --> 00:00:20.420 
the development of treatments for
muscular<00:00:17.279> dystrophy<00:00:17.760> I<00:00:19.100> currently<00:00:20.100> receive

00:00:20.420 --> 00:00:20.430 
muscular dystrophy I currently receive

00:00:20.430 --> 00:00:22.550 
muscular dystrophy I currently receive
grant<00:00:20.760> support<00:00:21.119> from<00:00:21.449> the<00:00:21.600> MDA<00:00:21.869> and<00:00:22.230> the<00:00:22.320> NDA

00:00:22.550 --> 00:00:22.560 
grant support from the MDA and the NDA

00:00:22.560 --> 00:00:23.810 
grant support from the MDA and the NDA
has<00:00:22.740> been<00:00:22.920> generously<00:00:23.279> supporting<00:00:23.730> our

00:00:23.810 --> 00:00:23.820 
has been generously supporting our

00:00:23.820 --> 00:00:26.779 
has been generously supporting our
research<00:00:24.090> program<00:00:24.510> for<00:00:24.750> about<00:00:24.840> five<00:00:25.140> years<00:00:25.789> my

00:00:26.779 --> 00:00:26.789 
research program for about five years my

00:00:26.789 --> 00:00:29.269 
research program for about five years my
research<00:00:27.599> interest<00:00:28.560> for<00:00:28.710> many<00:00:28.859> years<00:00:29.130> has

00:00:29.269 --> 00:00:29.279 
research interest for many years has

00:00:29.279 --> 00:00:31.429 
research interest for many years has
been<00:00:29.400> to<00:00:29.460> understand<00:00:30.119> how<00:00:30.449> cells<00:00:30.929> signal<00:00:31.349> to

00:00:31.429 --> 00:00:31.439 
been to understand how cells signal to

00:00:31.439 --> 00:00:34.220 
been to understand how cells signal to
one<00:00:31.560> another<00:00:31.800> a<00:00:32.099> little<00:00:32.239> over<00:00:33.239> 15<00:00:33.780> years<00:00:33.930> ago

00:00:34.220 --> 00:00:34.230 
one another a little over 15 years ago

00:00:34.230 --> 00:00:35.959 
one another a little over 15 years ago
we<00:00:34.620> identified<00:00:35.160> this<00:00:35.370> molecule<00:00:35.579> that<00:00:35.880> we

00:00:35.959 --> 00:00:35.969 
we identified this molecule that we

00:00:35.969 --> 00:00:38.840 
we identified this molecule that we
called<00:00:36.180> myostatin<00:00:37.040> my<00:00:38.040> statin<00:00:38.460> plays<00:00:38.670> a<00:00:38.700> very

00:00:38.840 --> 00:00:38.850 
called myostatin my statin plays a very

00:00:38.850 --> 00:00:41.150 
called myostatin my statin plays a very
important<00:00:39.329> role<00:00:39.360> in<00:00:39.570> muscle<00:00:39.960> because<00:00:40.590> it<00:00:40.890> acts

00:00:41.150 --> 00:00:41.160 
important role in muscle because it acts

00:00:41.160 --> 00:00:43.940 
important role in muscle because it acts
to<00:00:41.610> limit<00:00:42.059> muscle<00:00:42.420> growth<00:00:42.629> and<00:00:43.440> we<00:00:43.559> know<00:00:43.739> this

00:00:43.940 --> 00:00:43.950 
to limit muscle growth and we know this

00:00:43.950 --> 00:00:47.389 
to limit muscle growth and we know this
because<00:00:44.190> if<00:00:45.059> you<00:00:45.860> eliminate<00:00:46.860> the<00:00:46.890> function<00:00:47.309> of

00:00:47.389 --> 00:00:47.399 
because if you eliminate the function of

00:00:47.399 --> 00:00:48.560 
because if you eliminate the function of
the<00:00:47.489> gene<00:00:47.520> or<00:00:47.969> eliminate<00:00:48.329> the<00:00:48.420> gene

00:00:48.560 --> 00:00:48.570 
the gene or eliminate the gene

00:00:48.570 --> 00:00:50.959 
the gene or eliminate the gene
altogether<00:00:49.050> you<00:00:49.710> essentially<00:00:50.100> unleash

00:00:50.959 --> 00:00:50.969 
altogether you essentially unleash

00:00:50.969 --> 00:00:53.060 
altogether you essentially unleash
that's<00:00:51.390> inherent<00:00:52.170> capacity<00:00:52.289> of<00:00:52.710> the<00:00:52.770> muscle

00:00:53.060 --> 00:00:53.070 
that's inherent capacity of the muscle

00:00:53.070 --> 00:00:57.619 
that's inherent capacity of the muscle
to<00:00:53.160> grow<00:00:53.370> a<00:00:54.379> lot<00:00:55.379> of<00:00:55.559> the<00:00:55.680> focus<00:00:56.129> in<00:00:57.000> terms<00:00:57.300> of

00:00:57.619 --> 00:00:57.629 
to grow a lot of the focus in terms of

00:00:57.629 --> 00:00:59.299 
to grow a lot of the focus in terms of
developing<00:00:58.379> my<00:00:58.530> stat<00:00:58.800> inhibitors<00:00:59.280> for

00:00:59.299 --> 00:00:59.309 
developing my stat inhibitors for

00:00:59.309 --> 00:01:01.760 
developing my stat inhibitors for
clinical<00:00:59.820> use<00:00:59.850> has<00:01:00.449> focused<00:01:00.960> on<00:01:01.230> the<00:01:01.440> muscular

00:01:01.760 --> 00:01:01.770 
clinical use has focused on the muscular

00:01:01.770 --> 00:01:05.570 
clinical use has focused on the muscular
dystrophies<00:01:02.280> and<00:01:03.320> so<00:01:04.320> in<00:01:04.739> disease<00:01:05.309> states

00:01:05.570 --> 00:01:05.580 
dystrophies and so in disease states

00:01:05.580 --> 00:01:08.149 
dystrophies and so in disease states
like<00:01:06.210> muscular<00:01:06.510> dystrophy<00:01:07.140> where<00:01:07.799> the<00:01:07.920> muscle

00:01:08.149 --> 00:01:08.159 
like muscular dystrophy where the muscle

00:01:08.159 --> 00:01:10.160 
like muscular dystrophy where the muscle
is<00:01:08.250> degenerating<00:01:09.000> the<00:01:09.510> hope<00:01:09.720> would<00:01:09.990> be<00:01:10.020> that

00:01:10.160 --> 00:01:10.170 
is degenerating the hope would be that

00:01:10.170 --> 00:01:13.010 
is degenerating the hope would be that
we<00:01:10.470> might<00:01:10.650> be<00:01:10.799> able<00:01:10.920> to<00:01:11.750> manipulate<00:01:12.750> this

00:01:13.010 --> 00:01:13.020 
we might be able to manipulate this

00:01:13.020 --> 00:01:16.310 
we might be able to manipulate this
pathway<00:01:13.350> in<00:01:13.680> some<00:01:13.890> way<00:01:14.070> to<00:01:15.320> essentially

00:01:16.310 --> 00:01:16.320 
pathway in some way to essentially

00:01:16.320 --> 00:01:17.960 
pathway in some way to essentially
compensate<00:01:16.950> for<00:01:17.159> the<00:01:17.220> muscle<00:01:17.549> loss<00:01:17.700> that's

00:01:17.960 --> 00:01:17.970 
compensate for the muscle loss that's

00:01:17.970 --> 00:01:20.539 
compensate for the muscle loss that's
occurring<00:01:18.210> during<00:01:18.450> the<00:01:18.630> disease<00:01:19.490> now<00:01:20.490> we

00:01:20.539 --> 00:01:20.549 
occurring during the disease now we

00:01:20.549 --> 00:01:22.969 
occurring during the disease now we
don't<00:01:20.759> yet<00:01:21.030> know<00:01:21.229> for<00:01:22.229> sure<00:01:22.439> whether<00:01:22.740> the

00:01:22.969 --> 00:01:22.979 
don't yet know for sure whether the

00:01:22.979 --> 00:01:25.670 
don't yet know for sure whether the
strategy<00:01:23.460> will<00:01:23.670> work<00:01:23.700> in<00:01:24.060> humans<00:01:24.530> but<00:01:25.530> there

00:01:25.670 --> 00:01:25.680 
strategy will work in humans but there

00:01:25.680 --> 00:01:27.350 
strategy will work in humans but there
is<00:01:25.799> quite<00:01:26.159> a<00:01:26.189> bit<00:01:26.400> of<00:01:26.490> activity<00:01:26.759> going<00:01:27.210> on

00:01:27.350 --> 00:01:27.360 
is quite a bit of activity going on

00:01:27.360 --> 00:01:30.230 
is quite a bit of activity going on
there<00:01:27.720> are<00:01:28.200> at<00:01:28.380> least<00:01:28.409> four<00:01:29.400> or<00:01:29.579> five<00:01:29.759> clinical

00:01:30.230 --> 00:01:30.240 
there are at least four or five clinical

00:01:30.240 --> 00:01:32.660 
there are at least four or five clinical
trials<00:01:30.689> that<00:01:31.140> either<00:01:31.650> have<00:01:32.250> been<00:01:32.430> initiated

00:01:32.660 --> 00:01:32.670 
trials that either have been initiated

00:01:32.670 --> 00:01:35.600 
trials that either have been initiated
or<00:01:33.180> about<00:01:33.390> to<00:01:33.600> be<00:01:33.630> initiated<00:01:33.979> with<00:01:34.979> various<00:01:35.460> my

00:01:35.600 --> 00:01:35.610 
or about to be initiated with various my

00:01:35.610 --> 00:01:39.319 
or about to be initiated with various my
statin<00:01:36.030> inhibitors<00:01:36.450> so<00:01:37.850> we're<00:01:38.850> optimistic

00:01:39.319 --> 00:01:39.329 
statin inhibitors so we're optimistic

00:01:39.329 --> 00:01:41.899 
statin inhibitors so we're optimistic
that<00:01:40.020> one<00:01:40.560> way<00:01:40.710> or<00:01:40.799> another<00:01:40.829> we'll<00:01:41.430> find<00:01:41.700> out

00:01:41.899 --> 00:01:41.909 
that one way or another we'll find out

00:01:41.909 --> 00:01:44.539 
that one way or another we'll find out
in<00:01:42.689> the<00:01:42.869> short<00:01:43.110> term<00:01:43.320> whether<00:01:43.829> the<00:01:44.100> strategy

00:01:44.539 --> 00:01:44.549 
in the short term whether the strategy

00:01:44.549 --> 00:01:46.700 
in the short term whether the strategy
will<00:01:44.700> work

00:01:46.700 --> 00:01:46.710 
will work

00:01:46.710 --> 00:01:50.130 
will work
help<00:01:47.710> MDA<00:01:48.220> research<00:01:48.850> to<00:01:49.210> keep<00:01:49.450> moving<00:01:49.690> forward

00:01:50.130 --> 00:01:50.140 
help MDA research to keep moving forward

00:01:50.140 --> 00:01:57.590 
help MDA research to keep moving forward
go<00:01:50.620> online<00:01:50.860> at<00:01:51.430> MDA<00:01:52.000> org<00:01:52.690> thank<00:01:53.380> you

00:01:57.590 --> 00:01:57.600 

00:01:57.600 --> 00:01:59.659 

you

